Skip to content

Clinical trials

Observational Mucopolysaccharidosis II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis II Phase: Observational Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20093
20111
20122
20131
20142
20173
20183
20191
20202
20212
20224

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Recruiting2
Active, not recruiting2
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire7
REGENXBIO Inc.3
Albert Einstein College of Medicine1
CENTOGENE GmbH Rostock1
Centre Hospitalier Universitaire de Liege1
Denali Therapeutics Inc.1
Duke University1
GlaxoSmithKline1
Green Cross Corporation1
Institut National de la Santé Et de la Recherche Médicale, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II26
Mucopolysaccharidosis I10
Sudden Infant Death10
Mucopolysaccharidosis VI9
Mucopolysaccharidosis IV7
Mucopolysaccharidoses6
Mucopolysaccharidosis VII6
Mucopolysaccharidosis III5
Wolman Disease4
Gaucher Disease3

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.